XML 93 R78.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets - Additional Information (Detail)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
product
Jun. 30, 2020
USD ($)
product
Dec. 31, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Goodwill [Line Items]            
Goodwill $ 527,475 $ 527,475 $ 419,504     $ 426,226
Impairment charges 1,000          
Intangible assets acquired   131,000        
Product rights intangible asset 1,323,585 1,323,585 1,200,535      
In-process research and development $ 381,115 $ 381,115 382,075      
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Creo Pharma Holding Limited            
Goodwill [Line Items]            
Carrying value, intangible assets sold         $ 7,000  
In-process research and development            
Goodwill [Line Items]            
Intangible assets impairment, number of products experiencing impairment | product   2        
Intangible assets impairment, number of in process products experiencing estimated launch date delays | product   1        
Marketed products            
Goodwill [Line Items]            
Intangible assets impairment, number of products experiencing impairment | product 3          
Intangible assets impairment, number of products experiencing price erosion | product 2          
Product rights            
Goodwill [Line Items]            
Product rights intangible asset $ 1,189,785 $ 1,189,785 1,197,535      
Product rights | JSP License And Commercialization Agreement            
Goodwill [Line Items]            
Product rights intangible asset       $ 50,000    
Customer relationships | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Creo Pharma Holding Limited            
Goodwill [Line Items]            
Carrying value, intangible assets sold       5,000    
Trade name            
Goodwill [Line Items]            
Product rights intangible asset 133,800 133,800 3,000      
Trade name | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Creo Pharma Holding Limited            
Goodwill [Line Items]            
Carrying value, intangible assets sold       $ 2,000    
Specialty            
Goodwill [Line Items]            
Goodwill 361,000 361,000 361,000      
Generics            
Goodwill [Line Items]            
Goodwill 93,000 93,000 $ 59,000      
Impairment charges   3,000        
Generics | In-process research and development            
Goodwill [Line Items]            
Impairment charges   $ 1,000        
Intangible assets impairment, number of products experiencing impairment | product   2        
Generics | Marketed products            
Goodwill [Line Items]            
Intangible assets impairment, number of products experiencing impairment | product   5        
Intangible assets impairment, number of products experiencing price erosion | product   4        
Generics | Cost of goods sold            
Goodwill [Line Items]            
Impairment charges   $ 2,000        
AvKARE            
Goodwill [Line Items]            
Goodwill $ 73,000 $ 73,000